TCL Archive Five NIH study section members resign over peer review of their grant proposals. Review inequitable for study section members, they say. June 24, 2005
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting October 26, 2007
TCL Archive Letrozole cuts risk of recurrent breast cancer in post-menopausal women. October 17, 2003
